235 related articles for article (PubMed ID: 34502280)
1. Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations.
Sakkiah S; Selvaraj C; Guo W; Liu J; Ge W; Patterson TA; Hong H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502280
[TBL] [Abstract][Full Text] [Related]
2. Simulations reveal increased fluctuations in estrogen receptor-alpha conformation upon antagonist binding.
Ng HL
J Mol Graph Model; 2016 Sep; 69():72-7. PubMed ID: 27580485
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
Chakraborty S; Levenson AS; Biswas PK
BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha.
Chakraborty S; Biswas PK
J Mol Model; 2014 Aug; 20(8):2338. PubMed ID: 25060147
[TBL] [Abstract][Full Text] [Related]
5. Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach.
Puranik NV; Srivastava P; Bhatt G; John Mary DJS; Limaye AM; Sivaraman J
Sci Rep; 2019 May; 9(1):7450. PubMed ID: 31092862
[TBL] [Abstract][Full Text] [Related]
6. Elucidating Binding Sites and Affinities of ERα Agonists and Antagonists to Human Alpha-Fetoprotein by In Silico Modeling and Point Mutagenesis.
Moldogazieva NT; Ostroverkhova DS; Kuzmich NN; Kadochnikov VV; Terentiev AA; Porozov YB
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019136
[TBL] [Abstract][Full Text] [Related]
7. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
[TBL] [Abstract][Full Text] [Related]
8. Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.
Ng HW; Zhang W; Shu M; Luo H; Ge W; Perkins R; Tong W; Hong H
BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S4. PubMed ID: 25349983
[TBL] [Abstract][Full Text] [Related]
9. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
Celik L; Lund JD; Schiøtt B
Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
[TBL] [Abstract][Full Text] [Related]
10. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
[TBL] [Abstract][Full Text] [Related]
11. Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations.
Méndez-Luna D; Martínez-Archundia M; Maroun RC; Ceballos-Reyes G; Fragoso-Vázquez MJ; González-Juárez DE; Correa-Basurto J
J Biomol Struct Dyn; 2015; 33(10):2161-72. PubMed ID: 25587872
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization of the binding interactions of various endogenous estrogen metabolites with human estrogen receptor α and β subtypes: a molecular modeling study.
Wang P; McInnes C; Zhu BT
PLoS One; 2013; 8(9):e74615. PubMed ID: 24098659
[TBL] [Abstract][Full Text] [Related]
13. Structural insight into the antagonistic action of diarylheptanoid on human estrogen receptor alpha.
Geetha Rani Y; Lakshmi BS
J Biomol Struct Dyn; 2019 Mar; 37(5):1189-1203. PubMed ID: 29557271
[TBL] [Abstract][Full Text] [Related]
14. Molecular docking, molecular dynamics simulation, and structure-based 3D-QSAR studies on estrogenic activity of hydroxylated polychlorinated biphenyls.
Li X; Ye L; Wang X; Wang X; Liu H; Qian X; Zhu Y; Yu H
Sci Total Environ; 2012 Dec; 441():230-8. PubMed ID: 23137989
[TBL] [Abstract][Full Text] [Related]
15. Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.
Zhao C; Koide A; Abrams J; Deighton-Collins S; Martinez A; Schwartz JA; Koide S; Skafar DF
J Biol Chem; 2003 Jul; 278(29):27278-86. PubMed ID: 12736255
[TBL] [Abstract][Full Text] [Related]
16. Computational insights on agonist and antagonist mechanisms of estrogen receptor α induced by bisphenol A analogues.
Cao H; Wang L; Cao M; Ye T; Sun Y
Environ Pollut; 2019 May; 248():536-545. PubMed ID: 30831350
[TBL] [Abstract][Full Text] [Related]
17. Heterodimeric GW7604 Derivatives: Modification of the Pharmacological Profile by Additional Interactions at the Coactivator Binding Site.
Knox AK; Kalchschmid C; Schuster D; Gaggia F; Gust R
J Med Chem; 2021 May; 64(9):5766-5786. PubMed ID: 33904307
[TBL] [Abstract][Full Text] [Related]
18. Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate.
Nose T; Tokunaga T; Shimohigashi Y
Toxicol Lett; 2009 Dec; 191(1):33-9. PubMed ID: 19666091
[TBL] [Abstract][Full Text] [Related]
19. Estrogenicity of halogenated bisphenol A: in vitro and in silico investigations.
Zhang J; Li T; Wang T; Yuan C; Zhong S; Guan T; Li Z; Wang Y; Yu H; Luo Q; Wang Y; Zhang T
Arch Toxicol; 2018 Mar; 92(3):1215-1223. PubMed ID: 29152682
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of binding and antagonism/downregulation of brilanestrant molecule in estrogen receptor-α via quantum mechanics/molecular mechanics, molecular dynamics and binding free energy calculations.
Chinnasamy K; Saravanan M; Poomani K
J Biomol Struct Dyn; 2020 Jan; 38(1):219-235. PubMed ID: 31038398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
